Impact of gastric banding on plasma adiponectin levels

Obesity Surgery

Volumn 16, Issue 8, 2006, Pages 1057-1061

  Diker, Dror ^a,b   Vishne, Tali ^c   Maayan, Rachel ^b   Weizman, Abraham ^b   Vardi, Pnina ^b   Dreznik, Zeev ^a,b   Seror, Dan ^a,b   Ram, Edward ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

Adiponectin; Adjustable gastric banding; Bariatric surgery; Insulin; Morbid obesity; Proinsulin; Weight loss

Indexed keywords

ADIPONECTIN;

ADULT; ANALYSIS OF VARIANCE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRIC BANDING; HUMAN; MALE; MORBID OBESITY; POST HOC ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; BODY MASS INDEX; FEMALE; GASTROPLASTY; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; WEIGHT LOSS;

EID: 33747138304     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206778026244     Document Type: Review

References (39)

1. Green SM. Obesity: prevalence, causes, health risks and treatment. Br J Nurs 1997; 6: 1181-5.
2. Hubert HB, Feinleib M, McNamara PM et al. Obesity as an independent risk factor for cardiovascular disease: a 26 year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-77.
3. Fontaine KR, Redden DT, Wang C et al. Years of life lost due to obesity. JAMA 2003; 289: 187-193.
4. Banegas JR, Lopez-Garcia E, Gutierrez-Fisac JL et al. A simple estimate of mortality attributable to excess weight in the European Union. Eur J Clin Nutr 2003; 57: 201-8.
5. Calle EE, Thun MJ, Petrelli JM et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-105.
6. Kokkoris P, Pi-Sunyer FX. Obesity and endocrine disease. Endocrinol Metab Clin North Am 2003; 32: 895-914.
7. Ram E, Vishne T, Diker D et al. Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA, and DHEA-S levels. Obes Surg 2005; 15: 1118-23.
8. Hu, E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-703.
9. Arita, Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
10. Matsuzawa Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 2005; 6: 7-14.
11. Duntas LH, Popovic V, Panotopoulos G. Adiponectin: novelties in metabolism and hormonal regulation. Nutr Neurosci 2004; 7: 195-200.
12. Ram E, Vishne T, Maayan R et al. The relationship between BMI, plasma leptin, insulin and proinsulin before and after laparoscopic adjustable gastric banding. Obes Surg 2005; 15: 1456-62.
13. Kopp HP, Krzyzanowska K, Mohlig M et al. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes 2005; 29: 766-71.
14. Reinehr T, Roth C, Menke T et al. Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 2004; 89: 3790-4.
15. Reinehr T, Roth CL, Alexy U et al. Ghrelin levels before and after reduction of overweight due to a low-fat high-carbohydrate diet in obese children and adolescents. Int J Obes 2005; 29: 362-8.
16. Valsamakis G, McTernan PG, Chetty R et al. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 2004; 53: 430-4.
17. Yang WS, Lee WJ, Funahashi T et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815-9.
18. Mousavinasab F, Tahtinen T, Jokelainen J et al. Lack of increase of serum adiponectin concentrations with a moderate weight loss during six months on a high-caloric diet in military service among a young male Finnish Population Endocrine 2005; 26: 65-70.
19. Marcell TJ, McAuley KA, Traustadottir T et al. Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism. 2005; 54: 533-41.
20. Xydakis AM, Case CC, Jones PH et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 2004; 89: 2697-703.
21. Abbasi F, Lamendola C, McLaughlin T et al. Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women. Metabolism 2004; 53: 280-3.
22. Fujimoto WY, Abbate AL, Kahn SE et al. The visceral adiposity syndrome in Japanese-American men. Obes Res 1994 2: 364-71.
23. Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9.
24. Baratta R, Amato S, Degano C et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 2004; 89: 2665-71.
25. Hulver MW, Zheng D, Tanner CJ et al. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 2002; 283: E861-E865
26. Ryan AS, Nicklas BJ, Berman DM et al. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes 2003; 27: 1066-71.
27. Boudou P, Sobngwi E, Mauvais-Jarvis F et al. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol 2003; 149: 421-4.
28. Poitou C, Lacorte JM, Coupaye M et al. Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obes Surg 2005; 15: 11-23.
29. Nadler ST, Stoehr JP, Schueler KL et al. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci USA 2000; 97: 11371-6.
30. Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ et al. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001; 280: E827-E847.
31. Arner P. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 2003; 14: 137-45.
32. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Bio 2000; 120: 1595-9.
33. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-5.
34. Fruebis J, Tsao TS, Javorschi S et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 2005-10.
35. Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-6.
36. Berg AH, Combs TP, Du X et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7: 947-53.
37. Combs TP, Berg AH, Obici S et al. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001; 108: 1875-81.
38. Kantarzis K, Fritsche A, Tschritter O et al. The association between plasma adiponectin and insulin sensitivity in humans depends on obesity. Obes Res 2005; 13: 1683-91.
39. Pfützner A, Kunt T, Hohberg C et al. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes. Diabetes Care 2004; 27: 682-7.